China's Health Regulator Defends Quality of Local Generic Drugs

SHANGHAI (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through...

SHANGHAI (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through...